- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02090868
An Oral Intake Screening Tool for Patients Receiving Non-Invasive Ventilation
How the Introduction of an Oral Intake Screening Tool Can Benefit Patients Receiving Non-Invasive Ventilation
This study aims to explore how the introduction of an oral intake screening tool can benefit patients requiring noninvasive ventilation. The Quality Care Commission has identified nutritional problems in hospital and there is much literature on the importance of nutrition when critically ill. Literature is short however concerning the specialized population of those requiring noninvasive ventilation and they are a high risk group of suffering from malnutrition.
This study will potentially benefit patients by improving their nutritional care through guided assessment and nurse training.
The study will use mixed methodology, a prospective cohort study and qualitative interviews. The prospective cohort study will collect data from patients prior to the tool introduction, the control group, and post the tool introduction, the exposure group. This will enable comparisons to be made between the exposure and the control groups.
Nurses will be interviewed in semi structured focus groups prior to tool introduction and post to identify themes and sub themes to give a deeper understanding of nutrition in hospital and to examine the use of the tool in practice.
Patients will be eligible if they are over 18 and requiring noninvasive ventilation and nurses will be eligible if they work on the high dependency unit. Patients will be visited daily and have four mid arm circumference measurements at day 1, day 3, day 7 and day 14. The other daily visits will involve collecting data, which is recorded as part of routine care.
Nurses will undergo 2 focus group interviews and a teaching session. The study will take place at St Mary's hospital funded by Imperial College London. The study will be split into two periods with a two week gap in between. Each period will last until 22 patient participants have been recruited.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Tipo di studio
Contatti e Sedi
Luoghi di studio
-
-
-
London, Regno Unito
- Imperial College Healthcare NHS Trust
-
London, Regno Unito, W2 1NY
- St Marys Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Patients
Inclusion Criteria:
- over 18 years old
- require non-invasive ventilation as defined by the protocol
Exclusion Criteria:
- Patients on the Liverpool Care Pathway
- Patients requiring nocturnal non-invasive ventilation only
- Patients with a tracheostomy
- Patients with a nasogastric feeding tube insitu on admission
- Patients with a PEG/RIG tube insitu on admission
Staff
Inclusion Criteria:
- full time employees
- work in the medical high dependency unit
Exclusion Criteria:
- staff only working bank or agency shifts on the medical high dependency unit
- staff who have not had formal high dependency/critical care training
- staff who do not work more than 5 shifts per month in the medical high dependency unit
- staff who have not held a full time post on Douglas Acute Admissions Unit for more than six months
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Pre Introduction
Pre tool introduction cohort 22 patient participants who will receive standard care (no patients were recruited)
|
|
|
Nurses
12 nurse participants who will take part in 2 focus group interviews and a teaching session (6 nurse participants were recruited)
|
|
|
Post Introduction
Pre tool introduction cohort 22 patient participants who's ability to eat and drink orally will be assessed using the Oral Intake Screening Tool (no patient participants were recruited)
|
A screening tool developed from a literature review and expert opinion.
It will be used by nurses to assess patients receiving non-invasive ventilation ability to eat and drink orally and suggest what actions should be taken if they are unable to do so
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Mid Arm Circumference Change
Lasso di tempo: Day 1, 3, 7, 14
|
Day 1, 3, 7, 14
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Fluid Intake Change
Lasso di tempo: Daily over 14 days
|
fluid intake from all sources eg intravenous, nasogastric, oral
|
Daily over 14 days
|
|
fluid balance change
Lasso di tempo: daily for 14 days
|
fluid intake minus fluid output
|
daily for 14 days
|
|
New formation of or worsening of existing pressure sores
Lasso di tempo: daily for 14 days
|
daily for 14 days
|
|
|
new diagnosis of aspiration pneumonia
Lasso di tempo: daily for 14 days
|
daily for 14 days
|
|
|
number of days requiring non-invasive ventilation
Lasso di tempo: 14 days
|
14 days
|
|
|
number of days requiring level 2 care
Lasso di tempo: 14 days
|
14 days
|
|
|
length of hospital stay
Lasso di tempo: 14 days
|
14 days
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Gary Frost, Imperial College London
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 13IC0065
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Oral Intake Screening Tool
-
Hospices Civils de LyonReclutamentoDisturbo della deglutizione | Disfagia sarcopanicaFrancia